Potential Prognostic Value of Native T1 in Pulmonary Hypertension Patients.

extracellular volume fraction late gadolinium enhancement native T1 patient outcomes pulmonary hypertension

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
13 Mar 2023
Historique:
received: 29 12 2022
revised: 02 03 2023
accepted: 07 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Native T1, extracellular volume fraction (ECV), and late gadolinium enhancement (LGE) characterize myocardial tissue and relate to patient prognosis in a variety of diseases, including pulmonary hypertension. The purpose of this study was to evaluate if left ventricle (LV) fibrosis measurements have prognostic value for cardiac outcomes in pulmonary hypertension subgroups. 54 patients with suspected pulmonary hypertension underwent right-heart catheterization and were classified into pulmonary hypertension subgroups: pre-capillary component (PreCompPH) and isolated post-capillary (IpcPH). Cardiac magnetic resonance imaging (MRI) scans were performed with the acquisition of balanced cine steady-state free precession, native T1, and LGE pulse sequences to measure cardiac volumes and myocardial fibrosis. Associations between cardiac events and cardiac MRI measurements were analyzed within PreCompPH and IpcPH patients. IpcPH: LV native T1 was higher in patients who experienced a cardiac event within two years vs. those who did not. In patients with LV native T1 > 1050 ms, the rate of cardiac events was higher. ECV and quantitative LGE did not differ between groups. PreCompPH: native T1, ECV, and quantitative/qualitative LGE did not differ between patients who experienced a cardiac event within two years vs. those who did not. LV native T1 may have potential value for forecasting cardiac events in IpcPH, but not in PreCompPH, patients.

Identifiants

pubmed: 36983931
pii: life13030775
doi: 10.3390/life13030775
pmc: PMC10051677
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Bayer HealthCare Pharmaceuticals Inc.
ID : 205106

Références

Chest. 2009 Mar;135(3):794-804
pubmed: 19265089
J Magn Reson Imaging. 2022 Jul;56(1):234-245
pubmed: 34694050
Diagnostics (Basel). 2022 Mar 01;12(3):
pubmed: 35328169
Circulation. 2012 Sep 4;126(10):1206-16
pubmed: 22851543
Circulation. 2010 Jul 13;122(2):164-72
pubmed: 20585012
Thorax. 2009 Oct;64(10):883-8
pubmed: 19546096
Life (Basel). 2022 Apr 28;12(5):
pubmed: 35629323
Eur Heart J. 2007 May;28(10):1250-7
pubmed: 17242010
J Am Coll Cardiol. 2018 Feb 20;71(7):766-778
pubmed: 29447739
Sci Rep. 2019 Dec 27;9(1):20168
pubmed: 31882822
Circulation. 2002 Sep 17;106(12):1477-82
pubmed: 12234951
J Am Coll Cardiol. 2016 Dec 13;68(23):2525-2536
pubmed: 27931609
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545968
Eur Respir J. 2015 Jun;45(6):1603-12
pubmed: 25882798
PLoS One. 2021 Nov 29;16(11):e0260456
pubmed: 34843578
Diagnostics (Basel). 2022 Dec 27;13(1):
pubmed: 36611364
Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):1004-12
pubmed: 24686257
Lancet Respir Med. 2020 Sep;8(9):873-884
pubmed: 32730752
Eur Radiol. 2019 Aug;29(8):4357-4367
pubmed: 30617490
Am J Cardiol. 2016 Oct 1;118(7):1057-62
pubmed: 27567135
Ann Intern Med. 1991 Sep 1;115(5):343-9
pubmed: 1863023
Int J Cardiovasc Imaging. 2016 Mar;32(3):451-9
pubmed: 26472581
Eur Heart J. 2014 Mar;35(10):657-64
pubmed: 23756336
Heart. 2015 Jan;101(1):37-43
pubmed: 25214501
Eur Radiol. 2010 May;20(5):1149-59
pubmed: 20094890
J Am Coll Cardiol. 2016 Jul 26;68(4):368-78
pubmed: 27443433
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
J Am Soc Echocardiogr. 2020 Feb;33(2):161-170
pubmed: 31836269
Eur Radiol. 2017 Jan;27(1):157-166
pubmed: 27121929
Eur Respir Rev. 2012 Dec 1;21(126):338-46
pubmed: 23204122
Eur Heart J. 2022 Oct 11;43(38):3618-3731
pubmed: 36017548
J Am Coll Cardiol. 2018 Feb 13;71(6):703-705
pubmed: 29420969
Circulation. 1994 Apr;89(4):1733-44
pubmed: 8149539
J Cardiovasc Magn Reson. 2018 Jan 03;20(1):2
pubmed: 29298704
JACC Cardiovasc Imaging. 2016 Jan;9(1):14-23
pubmed: 26684970
J Cardiovasc Magn Reson. 2018 Dec 3;20(1):78
pubmed: 30501639
JACC Cardiovasc Imaging. 2020 Jul;13(7):1521-1530
pubmed: 32199848
J Am Coll Cardiol. 2011 Dec 6;58(24):2511-9
pubmed: 22133851
Cardiol Clin. 1992 Feb;10(1):165-83
pubmed: 1739957
Heart. 2012 Dec;98(24):1805-11
pubmed: 22760869
JACC Cardiovasc Imaging. 2019 May;12(5):936-938
pubmed: 30660545

Auteurs

John W Cerne (JW)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.

Christina Shehata (C)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.

Ann Ragin (A)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.

Ashitha Pathrose (A)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.

Manik Veer (M)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.

Kamal Subedi (K)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.

Bradley D Allen (BD)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.

Ryan J Avery (RJ)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.

Michael Markl (M)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.
Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA.

James C Carr (JC)

Department of Radiology, Feinberg School of Medicine, Northwestern, Chicago, IL 60611, USA.

Classifications MeSH